Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Bloomfield, Gerald S ^a   Hogan, Joseph W ^b   Keter, Alfred ^c   Sang, Edwin ^c   Carter, E Jane ^d   Velazquez, Eric J ^a   Kimaiyo, Sylvester ^c  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b BROWN UNIVERSITY   (United States)

^c MOI UNIVERSITY   (Kenya)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR;

ADOLESCENT; ADULT; AGE; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; KENYA; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT CARE; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; AGED; CARDIOVASCULAR DISEASE; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; HIV SEROPOSITIVITY; HUMANS; HYPERTENSION; KENYA; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; YOUNG ADULT;

EID: 79960302302     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022288     Document Type: Article

References (46)

1. McDonald CL, Kaltman JR, (2009) Cardiovascular disease in adult and pediatric HIV/AIDS. J Am Coll Cardiol 54: 1185-1188.
2. Klein D, Hurley LB, Quesenberry CP, Sidney S, (2002) Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr 30: 471-477.
3. Guaraldi G, Stentarelli C, Zona S, Orlando G, Carli F, et al. (2010) Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects. Atherosclerosis 208: 222-227.
4. Grunfeld C, Delaney JAC, Wanke C, Currier JS, Scherzer R, et al. (2009) Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS 23: 1841-1849.
5. Ntsekhe M, Hakim J, (2005) Impact of human immunodeficiency virus infection on cardiovascular disease in Africa. Circulation 112: 3602-3607.
6. Randell P, Moyle G, (2009) Antiretroviral therapy with heart. Am J Ther 16: 579-584.
7. Mutimura E, Crowther NJ, Stewart A, Cade WT, (2008) The human immunodeficiency virus and the cardiometabolic syndrome in the developing world: an African perspective. J Cardiometab Syndr 3: 106-110.
8. Lazar JM, Wu X, Shi Q, Kagame A, Cohen M, et al. (2009) Arterial wave reflection in HIV-infected and HIV-uninfected Rwandan women. AIDS Res Hum Retroviruses 25: 877-882.
9. Mutimura E, Stewart A, Rheeder P, Crowther NJ, (2007) Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 46: 451-455.
10. Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, et al. (2008) Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 371: 1417-1426.
11. Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte ADA, et al. (2007) Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 356: 1723-1735.
12. Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D, et al. (2003) Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 17: 2479-2486.
13. Holmberg SD, Moorman AC, Williamson JM, Tong TC, Ward DJ, et al. (2002) Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 360: 1747-1748.
14. Joint United Nations Programme on HIV/AIDS (UNAIDS) (2008) Report on the global HIV/AIDS epidemic. Geneva. Accessed on October 12, 2010 from http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008_Global_report.asp.
15. Joubert J, Bradshaw D, (2006) Population ageing and health challenges in South Africa. In: Steyn K, Fourie J, Temple N, editors. Chronic Diseases of Lifestyle in South Africa 1995-2005. Cape Town South African Medical Research Council. Accessed on October 12, 2010 from http://www.mrc.ac.za/chronic/cdlchapter15.pdf.
16. Einterz RM, Kimaiyo S, Mengech HNK, Khwa-Otsyula BO, Esamai F, et al. (2007) Responding to the HIV pandemic: the power of an academic medical partnership. Acad Med 82: 812-818.
17. Yiannoutsos CT, An M-W, Frangakis CE, Musick BS, Braitstein P, et al. (2008) Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS ONE 3: e3843.
18. Mamlin BW, Biondich PG, (2005) AMPATH Medical Record System (AMRS): collaborating toward an EMR for developing countries. AMIA Annu Symp Proc pp. 490-494.
19. WHO Expert Committee on Physical Status (1995) The Use and Interpretation of Anthropometry. Geneva. Accessed on July 29, 2010 from http://whqlibdoc.who.int/trs/WHO_TRS_854.pdf.
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
21. WHO World Health Statistics (2009) Geneva. Accessed on July 27, 2010 from http://www.who.int/whosis/whostat/2009/en/index.html.
22. Kannel WB, Giordano M, (2004) Long-term cardiovascular risk with protease inhibitors and management of the dyslipidemia. Am J Cardiol 94: 901-906.
23. Sklar P, Masur H, (2003) HIV infection and cardiovascular disease-is there really a link? N Engl J Med 349: 2065-2067.
24. Jericó C, Knobel H, Montero M, Sorli ML, Guelar A, et al. (2005) Hypertension in HIV-infected patients: prevalence and related factors. Am J Hypertens 18: 1396-1401.
25. Barbaro G, (2006) Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection. Curr HIV Res 4: 79-85.
26. WHO WHO Global Infobase. Accessed on July 26, 2010 from https://apps.who.int/infobase/Index.aspx.
27. Guaraldi G, Zona S, Alexopoulos N, Orlando G, Carli F, et al. (2009) Coronary aging in HIV-infected patients. Clin Infect Dis 49: 1756-1762.
28. Wilson SL, Scullard G, Fidler SJ, Weber JN, Poulter NR, (2009) Effects of HIV status and antiretroviral therapy on blood pressure. HIV Medicine 10: 388-394.
29. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, et al. (2006) CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 355: 2283-2296.
30. Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Buckner K, et al. (2010) Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clin Infect Dis 51: 435-447.
31. Arruda JE, Lacerda HR, Moura LC, Albuquerque MdF, Miranda Filho D, et al. (2010) Risk factors related to hypertension among patients in a cohort living with HIV/AIDS. Braz J Infect Dis 14: 281-287.
32. Bergersen BM, Sandvik L, Dunlop O, Birkeland K, Bruun JN, (2003) Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients. Eur J Clin Microbiol Infect Dis 22: 731-736.
33. Crum-Cianflone N, Roediger MP, Eberly L, Headd M, Marconi V, et al. (2010) Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLoS ONE 5: e10106.
34. Thiébaut R, El-Sadr WM, Friis-Møller N, Rickenbach M, Reiss P, et al. (2005) Predictors of hypertension and changes of blood pressure in HIV-infected patients. Antivir Ther (Lond) 10: 811-823.
35. Crane HM, Van Rompaey SE, Kitahata MM, (2006) Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy. AIDS 20: 1019-1026.
36. Baekken M, Os I, Sandvik L, Oektedalen O, (2008) Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy. J Hypertens 26: 2126-2133.
37. Kaplan RC, Kingsley LA, Sharrett AR, Li X, Lazar J, et al. (2007) Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis 45: 1074-1081.
38. Central Bureau of Statistics (CBS) [Kenya], Ministry of Health (MOH) [Kenya], ORC Macro (2004) Kenya Demographic and Health Survey 2003 Calverton CBS, MOH and ORC Macro.
39. Stevens J, Plankey MW, Williamson DF, Thun MJ, Rust PF, et al. (1998) The body mass index-mortality relationship in white and African American women. Obesity Research 6: 268-277.
40. Taylor HA, Coady SA, Levy D, Walker ER, Vasan RS, et al. (2010) Relationships of BMI to cardiovascular risk factors differ by ethnicity. Obesity (Silver Spring, Md) 18: 1638-1645.
41. Jones CY, Hogan JW, Snyder B, Klein RS, Rompalo A, et al. (2003) Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis 37 (Suppl 2): S69-80.
42. Westaway MS, (2010) The impact of chronic diseases on the health and well-being of South Africans in early and later old age. Arch Gerontol Geriatr 50: 213-221.
43. Steyn K, Sliwa K, Hawken S, Commerford P, Onen C, et al. (2005) Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation 112: 3554-3561.
44. Fuster V, Kelly BB, eds. (2010) Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health Washington, DC Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries; Institute of Medicine.
45. Sridhar D, Batniji R, (2008) Misfinancing global health: a case for transparency in disbursements and decision making. Lancet 372: 1185-1191.
46. Bloomfield GS, Kimaiyo S, Carter EJ, Binanay C, Corey GR, et al. (2011) Chronic noncommunicable cardiovascular and pulmonary disease in sub-Saharan Africa: An academic model for countering the epidemic. Am Heart J 161: 842-847.